Video 10
Disclaimer: Individual results vary. Local etanercept treatment for the indications below is off-label. Please see the Legal Disclaimer. Maintenance dosing, usually weekly, but sometimes as little as monthly, is necessary for optimal effect. The methods of local etanercept treatment utilized for these patients are patented inventions of the INR[1].
"Now she's eating solid food": sustained improvement (2009)* video length 3:09

The patient's daughter-in-law documents the improvements sustained through the first five months of treatment with local etanercept in a patient with severe dementia who flew to the INR from Hawaii for treatment. See Tobinick E, TNF Modulation for treatment of Alzheimer's disease: rationale and current evidence, CNS Drugs 2009 September 23(9):713-25.
INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles (310) 824-6199 Orange County: 361 Hospital Road, Suite 428 Newport Beach

Copyright ©2010, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; 7,629,311; Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.
<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>